Melanoma/Skin Cancer News

A single dose of lifileucel conferred an objective response in nearly one-third of patients with advanced unresectable or metastatic melanoma, results from the phase 2 C-144-01 trial showed.

A study presented at this year’s ASCO Quality Care Symposium examined predictors of compliance with payer-led oncology clinical pathways.

Sunburns early in life may be associated with melanoma or cutaneous squamous cell carcinoma later in life, according to a study.

Cancer death rates declined broadly between 2015 and 2019 in the United States as overall incidence remained generally stable, according to the Annual Report to the Nation on the Status of Cancer.

NASHVILLE, Tenn. — Patients who received immune checkpoint inhibitor therapy may have a greater risk for sarcoidosis, according to study results presented at CHEST Annual Meeting.

The U.S. Preventive Services Task Force has released a draft recommendation stating there is not enough evidence to advocate for or against skin cancer screening in asymptomatic adults and adolescents.

Individuals who undergo skin screenings experience higher rates of biopsies and melanoma, according to a study.

More than half of patients had an objective response to first-line nivolumab for locally advanced or metastatic cutaneous squamous cell carcinoma, phase 2 study results published in Cancer showed.

Nivolumab conferred a statistically significant and clinically meaningful improvement in recurrence-free survival vs. placebo among patients with completely resected stage IIB or IIC melanoma, according to the agent’s manufacturer.

GENEVA — Factors such as age and comorbidities appeared associated with longer time to melanoma diagnosis, according to study results presented at World Cancer Congress.